Renjing Biology

About:

Renjing Biotech is engaged in the research and development of drugs based on messenger ribonucleic acid.

Website: https://rinuagene.com/

Top Investors: K2VC, Chang'an Capital, Jiang Guangce

Description:

Renjing Biotechnology is a biopharmaceutical company. It also engages in the development of therapeutic tumor vaccines, tumor immunotherapy drugs, and protein substitutes, providing customers with advanced therapeutic solutions.

Total Funding Amount:

100M CNY

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2021-02-22

Contact Email:

rinuagene(AT)rinuagene.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-02-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai